136 related articles for article (PubMed ID: 3283622)
1. [Chemotherapy of chronic myelocytic leukemia. Status of the German Multicenter Study on busulfan versus hydroxyurea versus alpha interferon, October 1897].
Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H
Onkologie; 1988 Feb; 11(1):25-9. PubMed ID: 3283622
[TBL] [Abstract][Full Text] [Related]
2. Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.
Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H
Blut; 1988 Feb; 56(2):87-91. PubMed ID: 3277680
[TBL] [Abstract][Full Text] [Related]
3. [Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)].
Hehlmann R; Heimpel H; Heinze B; Georgii A; Kolb HJ; Hossfeld DK; von Wussow P; Hochhaus A; Griesshammer M; Diehl V
Onkologie; 1991 Feb; 14(1):66-73. PubMed ID: 2057176
[TBL] [Abstract][Full Text] [Related]
4. The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Hehlmann R; Heimpel H; Kolb HJ; Heinze B; Hochhaus A; Griesshammer M; Pralle H; Queisser WP; Essers U; Falge C
Leuk Lymphoma; 1993; 11 Suppl 1():159-68. PubMed ID: 8251890
[TBL] [Abstract][Full Text] [Related]
5. [Prospective controlled study of therapy of chronic myeloid leukemia (CML)].
Hehlmann R; Heimpel H; Hossfeld DK; Köpcke W; Kolb HJ; Löffler H; Pralle H; Queisser W; Anger B; Bergmann L
Onkologie; 1987 Feb; 10(1):28-33. PubMed ID: 3295623
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Hochhaus A; Heinze B
Blood; 1994 Dec; 84(12):4064-77. PubMed ID: 7994025
[TBL] [Abstract][Full Text] [Related]
7. Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group.
Hehlmann R; Heimpel H; Griesshammer M; Kolb HJ; Heinze B; Hossfeld DK; Wickramanayake PD; Essers U; Thiele J; Georgii A
Leukemia; 1992; 6 Suppl 3():110S-114S. PubMed ID: 1602805
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.
Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Heinze B; Georgii A
Blood; 1993 Jul; 82(2):398-407. PubMed ID: 8329700
[TBL] [Abstract][Full Text] [Related]
9. Approaches to the treatment of chronic myeloid leukemia.
Savage DG; Goldman JM
Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials. Chronic myeloid leukemia trialists' collaborative group.
Br J Haematol; 2000 Sep; 110(3):573-6. PubMed ID: 10997966
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.
Hehlmann R; Kister P; Willer A; Simon M; Schenk M; Seifarth W; Papakonstantinou G; Saussele S; Kolb HJ; Ansari H
Leukemia; 1994 Apr; 8 Suppl 1():S127-32. PubMed ID: 8152279
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
Anger B; Porzsolt F; Leichtle R; Heinze B; Bartram C; Heimpel H
Blut; 1989 Jun; 58(6):275-8. PubMed ID: 2736308
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic myelogenous leukemia.
Griffin JD
Semin Hematol; 1986 Jul; 23(3 Suppl 1):20-6. PubMed ID: 3526559
[No Abstract] [Full Text] [Related]
14. Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia.
Rushing D; Goldman A; Gibbs G; Howe R; Kennedy BJ
Am J Clin Oncol; 1982 Jun; 5(3):307-13. PubMed ID: 6952759
[TBL] [Abstract][Full Text] [Related]
15. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
[TBL] [Abstract][Full Text] [Related]
16. [Two busulfan-resistant cases of CML (chronic myelogenous leukemia) with good response to alpha-interferon treatment].
Ogura H; Shirafuji N; Kumakawa T; Matsuda S; Horiuchi N; Kodo H; Fujii H; Asano S; Miwa S; Shinohara T
Rinsho Ketsueki; 1987 Sep; 28(9):1599-604. PubMed ID: 3481405
[No Abstract] [Full Text] [Related]
17. Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Hehlmann R; Heimpel H; Hossfeld DK; Hasford J; Kolb HJ; Löffler H; Pralle H; Queisser W; Hochhaus A; Tichelli A; Fett W; Schmitz N; Reiter A; Griesshammer M; Pfeifer W; Bümler M; Kamp T; Tobler A; Eimermacher H; Kuse R; Berger U; Ansari H
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S21-4. PubMed ID: 8769695
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
Hehlmann R; Ansari H; Hasford J; Heimpel H
Semin Hematol; 1993 Jul; 30(3 Suppl 3):44-8. PubMed ID: 8235707
[No Abstract] [Full Text] [Related]
19. Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
Berger U; Engelich G; Maywald O; Pfirrmann M; Hochhaus A; Reiter A; Metzgeroth G; Gnad U; Hasford J; Heinze B; Heimpel H; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Hehlmann R;
Leukemia; 2003 Sep; 17(9):1820-6. PubMed ID: 12970782
[TBL] [Abstract][Full Text] [Related]
20. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
